Trump Signs New TikTok Deal
Antifa Just Showed Everyone Why Trump Labeled Them a Domestic Terror Group
The Crudity of the Obsessive-Compulsive Left
No, Senator Van Hollen: Stations Choosing Not To Air Kimmel Isn’t Censorship
Rob Reiner Says Kamala Harris Memoir Got His Debate Watch Party Remarks Wrong
Five Years After the Pandemic, Violet Affleck Demands a Return to Permanent Mask...
State Rep. Marcia Morey (D-NC) Says 'No Correlation' Between Crime and Letting Criminals...
Starbucks Announces $1B Restructuring That Will Close Stores and Lay Off 900 Workers
Police Made Contact With Tyler Robinson By Rifle Drop Point Just 6 Hours...
Secretary of War Orders Hundreds of Senior Generals to Virginia For 'Rare, Urgent...
Trump’s HHS Overhauls Welfare Program with Focus on Accountability
'No One Is Above the Law': Former FBI Director James Comey Has Been...
800+ Pounds of Fentanyl Seized in Operation Targeting Sinaloa Cartel
Tulsa Man Charged With Attempting to Provide 3D-Printed Weapons to Al-Qaida
DOJ Sues Six States for Not Providing Voter Registration Rolls
Tipsheet

We're Already Seeing the Effects of Trump Nominating RFK Jr. to HHS

AP Photo/Ross D. Franklin

Vaccine stocks are continuing to fall after President-elect Donald Trump announced he would nominate Robert F. Kennedy Jr. to lead the Department of Health and Human Services. 

Advertisement

“We have a generational opportunity to bring together the greatest minds in science, medicine, industry, and government to put an end to the chronic disease epidemic,” Kennedy said in a statement Thursday after Trump nominated him.  

At 1204 GMT, shares in Britain's GSK (GSK.L), opens new tab were down 3.2% at their lowest in more than a year, while AstraZeneca and France's Sanofi (SASY.PA), opens new tab were down between 2.6% and 2.8% respectively. [...]

Sartorius (SATG.DE), opens new tab, a major supplier of biotech lab gear and substances, fell 3.8%.

Bavarian Nordic (BAVA.CO), opens new tab, which makes a vaccine for mpox, was down 16%, also hurt by third-quarter results

The Danish biotech firm's CEO voiced concerns that RFK Jr, as he is known, could fuel vaccine scepticism but also told Reuters that the U.S. response to the COVID-19 pandemic during Trump's first term made him confident about future bio-defence funding by the incoming U.S. administration.

German-listed shares of BioNtech (22UAy.DE), opens new tab, Pfizer's partner on COVID-19 vaccines, were down more than 10%, set for their biggest one-day fall since August.  [...]

In premarket trading, U.S. vaccine makers fell further after Thursday's declines, with Moderna (MRNA.O), opens new tab down 2.21% after hitting its lowest since April 2020 on Thursday and Novavax (NVAX.O), opens new tab 1.94% lower. 

Pfizer (PFE.N), opens new tab was marginally lower after falling to April lows a day earlier. (Reuters

Advertisement

"For too long, Americans have been crushed by the industrial food complex and drug companies who have engaged in deception, misinformation, and disinformation when it comes to Public Health," Trump said in a statement announcing Kennedy as his pick to lead HHS. "The Safety and Health of all Americans is the most important role of any Administration, and HHS will play a big role in helping ensure that everybody will be protected from harmful chemicals, pollutants, pesticides, pharmaceutical products, and food additives that have contributed to the overwhelming Health Crisis in this Country. Mr. Kennedy will restore these Agencies to the traditions of Gold Standard Scientific Research, and beacons of Transparency, to end the Chronic Disease epidemic, and to Make America Great and Healthy Again!"

Advertisement

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos